PMID- 37786466 OWN - NLM STAT- MEDLINE DCOM- 20231004 LR - 20231012 IS - 1735-3688 (Electronic) IS - 0253-0716 (Print) IS - 0253-0716 (Linking) VI - 48 IP - 5 DP - 2023 Sep TI - Association of Insomnia with Anxiety and Depression in Type 2 Diabetic Patients: A Cross-Sectional Study. PG - 448-455 LID - 10.30476/ijms.2023.96017.2755 [doi] AB - BACKGROUND: Type 2 diabetes mellitus (T2DM) is associated with sleep disorders, which in turn may lead to anxiety and depression. Sleep deprivation impairs glucose metabolism causing a decrease in insulin sensitivity and glucose tolerance. The present study aimed to determine the association of insomnia with anxiety and depression in patients with T2DM. METHODS: A cross-sectional study was conducted in 2020 at the Endocrinological Department of City Clinical Hospital numero sign1, affiliated with Astana Medical University (Astana, Kazakhstan). A total of 376 patients with decompensated T2DM were included in the study. Insomnia was assessed using the Pittsburgh Sleep Quality Index (PSQI) and Insomnia Severity Index (ISI). Anxiety and depression were assessed using the Hospital Anxiety and Depression Scale (HADS). Multivariable logistic regression was used to assess the association of insomnia with anxiety and depression. RESULTS: All patients showed signs of sleep disturbances. Based on the HADS cutoff score >8, anxiety and depression were observed in 48 (12.80%) and 46 (12.20%) patients, respectively. PSQI, ISI, and HADS indicators were associated with an increased risk of anxiety and depression symptoms. In terms of anxiety, the adjusted odds ratio for PSQI and ISI scores were 1.09 (P=0.08) and 1.07 (P=0.01), respectively. These for depression were 1.10 (P=0.06) and 1.07 (P=0.01), respectively. CONCLUSION: Sleep quality is an important indicator of psychological health in patients with T2DM, especially those who exhibit signs of anxiety and depression. CI - Copyright: (c) Iranian Journal of Medical Sciences. FAU - Shinalieva, Karlyghash AU - Shinalieva K AD - Department of Neurology, National Joint Stock Company, Medical University Astana, Astana, Kazakhstan. FAU - Kasenova, Asemgul AU - Kasenova A AD - Department of Neurology, National Joint Stock Company, Medical University Astana, Astana, Kazakhstan. FAU - Akhmetzhanova, Zauresh AU - Akhmetzhanova Z AD - Department of Neurology, National Joint Stock Company, Medical University Astana, Astana, Kazakhstan. FAU - Alzhanova, Dinara AU - Alzhanova D AD - Department of Neurology, National Joint Stock Company, Medical University Astana, Astana, Kazakhstan. FAU - Eszhanova, Laura AU - Eszhanova L AD - Department of Neurology, National Joint Stock Company, Medical University Astana, Astana, Kazakhstan. FAU - Bekenova, Ainur AU - Bekenova A AD - Department of Neurology, National Joint Stock Company, Medical University Astana, Astana, Kazakhstan. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - Iran TA - Iran J Med Sci JT - Iranian journal of medical sciences JID - 8104374 SB - IM MH - Humans MH - *Sleep Initiation and Maintenance Disorders/complications/epidemiology MH - Cross-Sectional Studies MH - Depression/complications/epidemiology MH - *Diabetes Mellitus, Type 2/complications/epidemiology MH - Anxiety/complications/epidemiology PMC - PMC10541539 OTO - NOTNLM OT - Anxiety OT - Depression OT - Sleep disorders OT - Type 2 diabetes mellitus COIS- None declared. EDAT- 2023/10/03 06:47 MHDA- 2023/10/04 06:43 PMCR- 2023/09/01 CRDT- 2023/10/03 03:38 PHST- 2022/07/06 00:00 [received] PHST- 2022/10/04 00:00 [revised] PHST- 2022/11/11 00:00 [accepted] PHST- 2023/10/04 06:43 [medline] PHST- 2023/10/03 06:47 [pubmed] PHST- 2023/10/03 03:38 [entrez] PHST- 2023/09/01 00:00 [pmc-release] AID - IJMS-48-5 [pii] AID - 10.30476/ijms.2023.96017.2755 [doi] PST - ppublish SO - Iran J Med Sci. 2023 Sep;48(5):448-455. doi: 10.30476/ijms.2023.96017.2755.